Veracyte’s Nasal Swab Test Gets Clinical Validation for Lung Cancer Risk Assessment
Clinical validation data shows that Veracyte's Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.
Clinical validation data shows that Veracyte's Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.
Patients with a heart muscle injury caused by other heart conditions benefitted the most from the new troponin measurement method.
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Universal DX has announced a strategic collaboration with Quest Diagnostics to improve colorectal cancer screening in the United States.
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups.
Aqtual demonstrated its platform can identify synovial gene expression signatures in patients with rheumatoid arthritis using a blood test.
Bio-Rad Laboratories expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments.
Researchers discovered a new method for capturing many proteins in nano-sized traps, where they can be studied in a new way.
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Investigators developed an automated health maintenance tool to prompt physicians to screen for chronic kidney disease in diabetes patients.
The FDA granted 510(k) clearance to BD's Respiratory Viral Panel for the BD MAX System, a diagnostic test that ID's respiratory viruses.
Siemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.